Category Archives: Business and Investments

Latest From Business and Investments

BIO Investor Forum Company Snapshot: DLVR Therapeutics

DLVR

DLVR Therapeutics will be presenting in the Discovery Company Track at the upcoming BIO Investor Forum. Below, this early-stage company based in Ontario, answers our snapshot questions to provide attendees and readers with more perspective on their work. Company Snapshot What is your company’s lead product or technology?  DLVR is developing an innovative nanoparticle for delivery of nucleotides, such as small interfering RNA (siRNA). Our key differentiator is the synthesis of an HDL-mimetic phospholipid-based particle Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Top Biotech States Ranked

We here at BIO prefer to stay away from ranking states. After all, every state is different. Bioscience economic development in a nation as large and diverse as the United States is as varied as the country itself. A complex array of factors influence the allocation of resources and the nature of bioscience industry development: Presence of Universities Talent in the workforce Climate and geography Sufficiency of business capital Historical economic influences Ultimately, these characteristics Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , ,

BIO’s Jobs Listing Website Connects Industry with Talent

admin-ajax115x76

Less than a month after BIO Jobs was launched, it has already attracted over 37,000 unique visitors. This is quite a feat for a website uniquely focused on facilitating biotechnology employment opportunities. BIO Jobs is the only site of its kind catering to the specialized employment requirements of biotechnology companies. Because many fields within this industry require specific skills and training, it can often be difficult to find qualified candidates for position openings. BIO Jobs offers the following Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San Francisco. Read below to learn more about their antibodies portfolio, what differentiates their company for the competition, and other interesting facts about the company. Company Snapshot What is your company’s lead product or technology? NovelMed has developed a portfolio of fully humanized monoclonal antibodies that selectively target only the disease-associated Complement System. As such, NovelMed’s antibodies are active against multiple Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

GAINing Ground in Antibiotics

GAIN

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an urgent need to develop new and effective antibiotics. One measure designed to spur such development is the Generating Antibiotics Incentives Now (GAIN) Act, which was enacted last year. The law provides an additional five years of market exclusivity and priority FDA review for innovative antibiotics that target qualifying pathogens. Much of the current research in the field is being done Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , ,